Your browser doesn't support javascript.
loading
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.
Balch, Sara M; Vaz-Luis, Ines; Li, Tianyu; Tayob, Nabihah; Jain, Esha; Helvie, Karla; Buendia-Buendia, Jorge E; Shannon, Erin; Isakoff, Steven J; Tung, Nadine M; Krop, Ian E; Lin, Nancy U; Wagle, Nikhil; Freedman, Rachel A.
Afiliación
  • Balch SM; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Vaz-Luis I; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1259, Boston, MA, 02215, USA.
  • Li T; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1259, Boston, MA, 02215, USA.
  • Tayob N; Institut Gustave Roussy, Unit INSERM 981, Villejuif, France.
  • Jain E; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Helvie K; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Buendia-Buendia JE; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Shannon E; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1259, Boston, MA, 02215, USA.
  • Isakoff SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1259, Boston, MA, 02215, USA.
  • Tung NM; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Krop IE; Cellarity, Inc., Cambridge, MA, USA.
  • Lin NU; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wagle N; Massachusetts General Hospital, Boston, MA, USA.
  • Freedman RA; Harvard Medical School, Boston, MA, USA.
Breast Cancer Res Treat ; 189(2): 411-423, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34302589

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos